Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial.
Isobel LavenderDanielle McCartneyNathaniel MarshallAnastasia SuraevChris IrwinAngela L D'RozarioChristopher J GordonBandana SainiRonald R GrunsteinBrendon YeeIain McGregorCamilla M HoyosPublished in: BMJ open (2023)
NCT05344170.